Ethical and Bias Considerations in Artificial Intelligence/Machine Learning.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

As artificial intelligence (AI) gains prominence in pathology and medicine, the ethical implications and potential biases within such integrated AI models will require careful scrutiny. Ethics and bias are important considerations in our practice settings, especially as an increased number of machine learning (ML) systems are being integrated within our various medical domains. Such ML-based systems have demonstrated remarkable capabilities in specified tasks such as, but not limited to, image recognition, natural language processing, and predictive analytics. However, the potential bias that may exist within such AI-ML models can also inadvertently lead to unfair and potentially detrimental outcomes. The source of bias within such ML models can be due to numerous factors but is typically categorized into 3 main buckets (data bias, development bias, and interaction bias). These could be due to the training data, algorithmic bias, feature engineering and selection issues, clinic and institutional bias (ie, practice variability), reporting bias, and temporal bias (ie, changes in technology, clinical practice, or disease patterns). Therefore, despite the potential of these AI-ML applications, their deployment in our day-to-day practice also raises noteworthy ethical concerns. To address ethics and bias in medicine, a comprehensive evaluation process is required, which will encompass all aspects of such systems, from model development through clinical deployment. Addressing these biases is crucial to ensure that AI-ML systems remain fair, transparent, and beneficial to all. This review will discuss the relevant ethical and bias considerations in AI-ML specifically within the pathology and medical domain.

Authors

  • Matthew G Hanna
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Computational Pathology and AI Center of Excellence (CPACE), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Liron Pantanowitz
    Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Brian Jackson
    Department of Pathology, University of Utah, Salt Lake City, Utah; ARUP Laboratories, Salt Lake City, Utah.
  • Octavia Palmer
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Computational Pathology and AI Center of Excellence (CPACE), University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Shyam Visweswaran
    University of Pittsburgh, Pittsburgh, PA, USA.
  • Joshua Pantanowitz
    Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Mustafa Deebajah
    Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
  • Hooman H Rashidi
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Computational Pathology and AI Center of Excellence (CPACE), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Electronic address: rashidihh@upmc.edu.